CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Genovis AB Company Snapshot
Genovis AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genovis AB with three other companies in this sector in Sweden: Intervacc AB (2018 sales of 35.60 million Swedish Kronor [US$3.63 million] ), PledPharma AB (publ) (28.21 million Swedish Kronor [US$2.88 million] of which 100% was Drug Formulations), and Bioinvent International AB (38.55 million Swedish Kronor [US$3.93 million] of which 100% was Drug Development).

Sales Analysis. During the year ended December of 2018, sales at Genovis AB were SEK 34.57 million (US$3.52 million). This is an increase of 51.2% versus 2017, when the company's sales were SEK 22.87 million. This was the fourth straight year of sales growth at Genovis AB.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Genovis AB
  Stock Performance Chart for Genovis AB
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 22.60
(Figures in Swedish Kronor)
1 Week -7.0%   13 Weeks 5.1%  
4 Weeks 0.4%   52 Weeks 283.1%  
 
Genovis AB Key Data:
  Ticker: GENO Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 34,567,980
(Year Ending Jan 2019).
Employees: 20
  Currency: Swedish Kronor Market Cap: 1,426,060,000
  Fiscal Yr Ends: December Shares Outstanding: 63,100,000
  Share Type: B Aktie Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.